In TRAIL‐resistant cancer cells, the DR pathway is often compromised because of various factors, such as the downregulation or loss of expression of DR4/DR5 or the overexpression of anti‐apoptotic proteins like c‐FLIP.55 This evidence concerns the gene TNFRSF10B and cancer.